Position in EXEL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,202,188
+$185,567 QoQ
Shares Held
22,095
-6.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#319
of 751 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mezzasalma Advisors, LLC holds $2,761,038 across 2 Biotechnology names. EXEL ranks #2 (43.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,500 | $1,558,850 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
22,095 | $1,202,188 |
All Filings in EXEL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,202,188 | 22,095 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,016,621 | 23,703 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,144,539 | 71,744 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,640,763 | 63,941 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $2,489,241 | 56,471 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,870,145 | 50,654 | Shares | Sole | 2025-04-18 | |
| No filing history on record for this holder in this stock. | ||||||